Structure

Physi-Chem Properties

Molecular Weight:  734.29
Volume:  731.693
LogP:  4.551
LogD:  2.392
LogS:  -4.468
# Rotatable Bonds:  12
TPSA:  181.19
# H-Bond Aceptor:  13
# H-Bond Donor:  2
# Rings:  6
# Heavy Atoms:  13

MedChem Properties

QED Drug-Likeness Score:  0.238
Synthetic Accessibility Score:  5.825
Fsp3:  0.525
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.341
MDCK Permeability:  9.155987936537713e-05
Pgp-inhibitor:  1.0
Pgp-substrate:  0.997
Human Intestinal Absorption (HIA):  0.034
20% Bioavailability (F20%):  0.918
30% Bioavailability (F30%):  0.993

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.241
Plasma Protein Binding (PPB):  85.17253875732422%
Volume Distribution (VD):  2.379
Pgp-substrate:  7.800715446472168%

ADMET: Metabolism

CYP1A2-inhibitor:  0.023
CYP1A2-substrate:  0.021
CYP2C19-inhibitor:  0.026
CYP2C19-substrate:  0.06
CYP2C9-inhibitor:  0.478
CYP2C9-substrate:  0.033
CYP2D6-inhibitor:  0.119
CYP2D6-substrate:  0.049
CYP3A4-inhibitor:  0.368
CYP3A4-substrate:  0.358

ADMET: Excretion

Clearance (CL):  4.686
Half-life (T1/2):  0.045

ADMET: Toxicity

hERG Blockers:  0.272
Human Hepatotoxicity (H-HT):  0.477
Drug-inuced Liver Injury (DILI):  0.966
AMES Toxicity:  0.035
Rat Oral Acute Toxicity:  0.214
Maximum Recommended Daily Dose:  0.305
Skin Sensitization:  0.114
Carcinogencity:  0.086
Eye Corrosion:  0.003
Eye Irritation:  0.01
Respiratory Toxicity:  0.966

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC474935

Natural Product ID:  NPC474935
Common Name*:   XHAFKIWZKZKHOE-JFNIHIAOSA-N
IUPAC Name:   n.a.
Synonyms:   7,9-Dibenzoyltaxumairol P
Standard InCHIKey:  XHAFKIWZKZKHOE-JFNIHIAOSA-N
Standard InCHI:  InChI=1S/C40H46O13/c1-21-27(49-22(2)41)19-40(47)34-32-38(7,33(53-36(45)26-16-12-9-13-17-26)31(51-24(4)43)30(21)37(40,5)6)28(52-35(44)25-14-10-8-11-15-25)18-29(50-23(3)42)39(32,46)20-48-34/h8-17,27-29,31-34,46-47H,18-20H2,1-7H3/t27-,28-,29-,31+,32-,33-,34-,38+,39-,40+/m0/s1
SMILES:  CC(=O)O[C@@H]1C2=C(C)[C@@H](OC(=O)C)C[C@@](C2(C)C)(O)[C@@H]2[C@H]3[C@@]([C@H]1OC(=O)c1ccccc1)(C)[C@@H](OC(=O)c1ccccc1)C[C@@H]([C@@]3(O)CO2)OC(=O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL488534
PubChem CID:   10865491
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000264] Organic acids and derivatives
      • [CHEMONTID:0000265] Carboxylic acids and derivatives
        • [CHEMONTID:0002995] Pentacarboxylic acids and derivatives

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO11554 Taxus sumatrana Species Taxaceae Eukaryota n.a. leaf n.a. DOI[10.1016/j.tet.2004.10.110]
NPO11554 Taxus sumatrana Species Taxaceae Eukaryota n.a. twig n.a. DOI[10.1016/j.tet.2004.10.110]
NPO11554 Taxus sumatrana Species Taxaceae Eukaryota leaves and twigs n.a. n.a. PMID[12502326]
NPO11554 Taxus sumatrana Species Taxaceae Eukaryota n.a. n.a. n.a. PMID[15679325]
NPO11554 Taxus sumatrana Species Taxaceae Eukaryota n.a. twig n.a. PMID[15679325]
NPO11554 Taxus sumatrana Species Taxaceae Eukaryota n.a. leaf n.a. PMID[15679325]
NPO11554 Taxus sumatrana Species Taxaceae Eukaryota n.a. n.a. n.a. PMID[18220355]
NPO11554 Taxus sumatrana Species Taxaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO11554 Taxus sumatrana Species Taxaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO11554 Taxus sumatrana Species Taxaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT91 Cell Line KB Homo sapiens IC50 = 12.8 ug.mL-1 PMID[558448]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 7.02 ug.mL-1 PMID[558448]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC474935 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.971 High Similarity NPC95810
0.971 High Similarity NPC125106
0.971 High Similarity NPC163719
0.971 High Similarity NPC472573
0.971 High Similarity NPC476974
0.971 High Similarity NPC57628
0.971 High Similarity NPC25768
0.971 High Similarity NPC472569
0.971 High Similarity NPC11685
0.971 High Similarity NPC95265
0.971 High Similarity NPC472570
0.971 High Similarity NPC188865
0.971 High Similarity NPC70716
0.964 High Similarity NPC471104
0.964 High Similarity NPC200471
0.964 High Similarity NPC184817
0.964 High Similarity NPC469349
0.964 High Similarity NPC70403
0.964 High Similarity NPC472572
0.964 High Similarity NPC470159
0.964 High Similarity NPC472568
0.964 High Similarity NPC472571
0.964 High Similarity NPC174982
0.964 High Similarity NPC96903
0.964 High Similarity NPC473088
0.964 High Similarity NPC472575
0.964 High Similarity NPC29704
0.964 High Similarity NPC476973
0.964 High Similarity NPC177940
0.964 High Similarity NPC470157
0.964 High Similarity NPC171525
0.964 High Similarity NPC158663
0.9635 High Similarity NPC16912
0.9568 High Similarity NPC475759
0.9568 High Similarity NPC241951
0.9568 High Similarity NPC475122
0.9568 High Similarity NPC470152
0.9565 High Similarity NPC34012
0.9562 High Similarity NPC97667
0.9562 High Similarity NPC171207
0.9504 High Similarity NPC281717
0.9496 High Similarity NPC163087
0.9493 High Similarity NPC472576
0.9493 High Similarity NPC41481
0.9493 High Similarity NPC97947
0.9493 High Similarity NPC118080
0.9493 High Similarity NPC87448
0.9493 High Similarity NPC27377
0.9493 High Similarity NPC291599
0.9493 High Similarity NPC224491
0.9437 High Similarity NPC476975
0.9437 High Similarity NPC270590
0.9437 High Similarity NPC266265
0.9437 High Similarity NPC471101
0.9437 High Similarity NPC301556
0.9437 High Similarity NPC92293
0.942 High Similarity NPC48017
0.942 High Similarity NPC4341
0.942 High Similarity NPC184747
0.942 High Similarity NPC211137
0.942 High Similarity NPC473613
0.942 High Similarity NPC473060
0.942 High Similarity NPC473081
0.942 High Similarity NPC473109
0.942 High Similarity NPC200592
0.942 High Similarity NPC473758
0.942 High Similarity NPC147880
0.942 High Similarity NPC473112
0.942 High Similarity NPC43241
0.942 High Similarity NPC275592
0.942 High Similarity NPC90614
0.942 High Similarity NPC476094
0.942 High Similarity NPC100913
0.942 High Similarity NPC473085
0.9371 High Similarity NPC473214
0.9371 High Similarity NPC470245
0.9362 High Similarity NPC472556
0.9348 High Similarity NPC210591
0.9348 High Similarity NPC475652
0.9348 High Similarity NPC214550
0.9306 High Similarity NPC470153
0.9301 High Similarity NPC473215
0.9291 High Similarity NPC38696
0.9281 High Similarity NPC472547
0.9275 High Similarity NPC283375
0.9275 High Similarity NPC183122
0.927 High Similarity NPC66761
0.927 High Similarity NPC17877
0.927 High Similarity NPC472577
0.927 High Similarity NPC195647
0.927 High Similarity NPC291638
0.9252 High Similarity NPC472393
0.9241 High Similarity NPC472548
0.922 High Similarity NPC191082
0.922 High Similarity NPC246480
0.922 High Similarity NPC177340
0.922 High Similarity NPC270498
0.922 High Similarity NPC147217
0.922 High Similarity NPC139067
0.922 High Similarity NPC473673
0.922 High Similarity NPC475429
0.9203 High Similarity NPC472551
0.9203 High Similarity NPC472545
0.9197 High Similarity NPC474608
0.9184 High Similarity NPC217091
0.9155 High Similarity NPC470231
0.9155 High Similarity NPC51314
0.9155 High Similarity NPC67777
0.9149 High Similarity NPC472546
0.9137 High Similarity NPC39549
0.9116 High Similarity NPC282239
0.9116 High Similarity NPC472549
0.911 High Similarity NPC477905
0.9097 High Similarity NPC217918
0.9065 High Similarity NPC472372
0.9065 High Similarity NPC472374
0.9054 High Similarity NPC106895
0.9041 High Similarity NPC51602
0.9028 High Similarity NPC473602
0.9028 High Similarity NPC209592
0.9028 High Similarity NPC48599
0.9007 High Similarity NPC477904
0.9007 High Similarity NPC183270
0.8986 High Similarity NPC473670
0.8986 High Similarity NPC34066
0.8986 High Similarity NPC21410
0.8973 High Similarity NPC91730
0.8973 High Similarity NPC469448
0.8973 High Similarity NPC31829
0.8966 High Similarity NPC473760
0.8951 High Similarity NPC91703
0.8944 High Similarity NPC266374
0.8933 High Similarity NPC471102
0.8912 High Similarity NPC471103
0.8912 High Similarity NPC197037
0.8905 High Similarity NPC147561
0.8897 High Similarity NPC240115
0.8889 High Similarity NPC34943
0.8873 High Similarity NPC475400
0.8859 High Similarity NPC26033
0.8859 High Similarity NPC228204
0.8859 High Similarity NPC473611
0.8859 High Similarity NPC469422
0.8844 High Similarity NPC254558
0.8844 High Similarity NPC7095
0.8844 High Similarity NPC112216
0.8828 High Similarity NPC127857
0.8819 High Similarity NPC477894
0.8808 High Similarity NPC469399
0.8803 High Similarity NPC472395
0.8803 High Similarity NPC472371
0.88 High Similarity NPC326235
0.88 High Similarity NPC323001
0.8792 High Similarity NPC472030
0.8792 High Similarity NPC158333
0.8792 High Similarity NPC473414
0.8792 High Similarity NPC304876
0.8792 High Similarity NPC265395
0.8792 High Similarity NPC472005
0.8792 High Similarity NPC134685
0.8792 High Similarity NPC248265
0.8792 High Similarity NPC237549
0.8792 High Similarity NPC11588
0.8792 High Similarity NPC472022
0.8792 High Similarity NPC77719
0.8792 High Similarity NPC229545
0.8792 High Similarity NPC1173
0.8792 High Similarity NPC219419
0.8792 High Similarity NPC257213
0.8792 High Similarity NPC242262
0.8792 High Similarity NPC249471
0.8792 High Similarity NPC256142
0.8784 High Similarity NPC101043
0.8784 High Similarity NPC306799
0.8777 High Similarity NPC472394
0.8776 High Similarity NPC60509
0.8776 High Similarity NPC250046
0.8776 High Similarity NPC76103
0.8776 High Similarity NPC81698
0.8767 High Similarity NPC20255
0.875 High Similarity NPC477623
0.875 High Similarity NPC192658
0.8742 High Similarity NPC318447
0.8742 High Similarity NPC322048
0.8733 High Similarity NPC112523
0.8733 High Similarity NPC469730
0.8733 High Similarity NPC473632
0.8733 High Similarity NPC132599
0.8733 High Similarity NPC114410
0.8733 High Similarity NPC259144
0.8733 High Similarity NPC114357
0.8733 High Similarity NPC155329
0.8716 High Similarity NPC165260
0.8716 High Similarity NPC161239
0.8716 High Similarity NPC198455
0.8699 High Similarity NPC125882
0.8699 High Similarity NPC92867
0.8699 High Similarity NPC471107
0.8699 High Similarity NPC471100
0.8699 High Similarity NPC311825

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC474935 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.821 Intermediate Similarity NPD8470 Clinical (unspecified phase)
0.8079 Intermediate Similarity NPD7236 Approved
0.8036 Intermediate Similarity NPD8434 Phase 2
0.8024 Intermediate Similarity NPD8407 Phase 2
0.7986 Intermediate Similarity NPD5952 Clinical (unspecified phase)
0.7952 Intermediate Similarity NPD8368 Discontinued
0.7941 Intermediate Similarity NPD8361 Approved
0.7941 Intermediate Similarity NPD8435 Approved
0.7941 Intermediate Similarity NPD8360 Approved
0.7935 Intermediate Similarity NPD7239 Suspended
0.7927 Intermediate Similarity NPD7799 Discontinued
0.7824 Intermediate Similarity NPD8424 Clinical (unspecified phase)
0.767 Intermediate Similarity NPD8485 Approved
0.7558 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7542 Intermediate Similarity NPD8486 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD7008 Discontinued
0.7485 Intermediate Similarity NPD7058 Phase 2
0.7485 Intermediate Similarity NPD7057 Phase 3
0.7484 Intermediate Similarity NPD8166 Discontinued
0.7414 Intermediate Similarity NPD8150 Discontinued
0.741 Intermediate Similarity NPD8127 Discontinued
0.7372 Intermediate Similarity NPD4628 Phase 3
0.7333 Intermediate Similarity NPD3764 Approved
0.7305 Intermediate Similarity NPD4198 Discontinued
0.7297 Intermediate Similarity NPD6007 Clinical (unspecified phase)
0.7285 Intermediate Similarity NPD7961 Discontinued
0.7273 Intermediate Similarity NPD7741 Discontinued
0.7251 Intermediate Similarity NPD5844 Phase 1
0.725 Intermediate Similarity NPD6273 Approved
0.7237 Intermediate Similarity NPD7966 Clinical (unspecified phase)
0.7234 Intermediate Similarity NPD2629 Approved
0.7234 Intermediate Similarity NPD5951 Approved
0.7215 Intermediate Similarity NPD6190 Approved
0.7195 Intermediate Similarity NPD37 Approved
0.7194 Intermediate Similarity NPD2181 Clinical (unspecified phase)
0.7186 Intermediate Similarity NPD6234 Discontinued
0.7179 Intermediate Similarity NPD7702 Clinical (unspecified phase)
0.7172 Intermediate Similarity NPD7163 Clinical (unspecified phase)
0.7172 Intermediate Similarity NPD5126 Approved
0.7172 Intermediate Similarity NPD5125 Phase 3
0.7169 Intermediate Similarity NPD4965 Approved
0.7169 Intermediate Similarity NPD4967 Phase 2
0.7169 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7169 Intermediate Similarity NPD4966 Approved
0.7152 Intermediate Similarity NPD7819 Suspended
0.7151 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7135 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7123 Intermediate Similarity NPD7457 Clinical (unspecified phase)
0.7117 Intermediate Similarity NPD7458 Discontinued
0.7105 Intermediate Similarity NPD8462 Phase 1
0.7093 Intermediate Similarity NPD7228 Approved
0.7055 Intermediate Similarity NPD3412 Clinical (unspecified phase)
0.705 Intermediate Similarity NPD6831 Clinical (unspecified phase)
0.7048 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7045 Intermediate Similarity NPD8313 Approved
0.7045 Intermediate Similarity NPD8312 Approved
0.7044 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7044 Intermediate Similarity NPD7003 Approved
0.7035 Intermediate Similarity NPD7473 Discontinued
0.7024 Intermediate Similarity NPD7075 Discontinued
0.6975 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6972 Remote Similarity NPD6858 Approved
0.6972 Remote Similarity NPD7094 Approved
0.697 Remote Similarity NPD6599 Discontinued
0.697 Remote Similarity NPD4380 Phase 2
0.6964 Remote Similarity NPD7768 Phase 2
0.6959 Remote Similarity NPD8404 Phase 2
0.6959 Remote Similarity NPD6232 Discontinued
0.6952 Remote Similarity NPD7497 Discontinued
0.6946 Remote Similarity NPD8455 Phase 2
0.6941 Remote Similarity NPD5494 Approved
0.6937 Remote Similarity NPD3750 Approved
0.6932 Remote Similarity NPD7240 Approved
0.6932 Remote Similarity NPD7685 Pre-registration
0.6929 Remote Similarity NPD2182 Approved
0.6909 Remote Similarity NPD6591 Clinical (unspecified phase)
0.6909 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6905 Remote Similarity NPD5402 Approved
0.6905 Remote Similarity NPD8443 Clinical (unspecified phase)
0.6894 Remote Similarity NPD7274 Clinical (unspecified phase)
0.689 Remote Similarity NPD6980 Clinical (unspecified phase)
0.6875 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6859 Remote Similarity NPD6355 Discontinued
0.6855 Remote Similarity NPD7266 Discontinued
0.6849 Remote Similarity NPD7610 Discontinued
0.6846 Remote Similarity NPD6287 Discontinued
0.6845 Remote Similarity NPD5760 Phase 2
0.6845 Remote Similarity NPD5761 Phase 2
0.6839 Remote Similarity NPD6663 Approved
0.6836 Remote Similarity NPD6764 Approved
0.6836 Remote Similarity NPD6765 Approved
0.6836 Remote Similarity NPD6559 Discontinued
0.6835 Remote Similarity NPD3748 Approved
0.6831 Remote Similarity NPD4141 Clinical (unspecified phase)
0.6826 Remote Similarity NPD7411 Suspended
0.681 Remote Similarity NPD6143 Clinical (unspecified phase)
0.6807 Remote Similarity NPD3226 Approved
0.6805 Remote Similarity NPD3817 Phase 2
0.6802 Remote Similarity NPD7199 Phase 2
0.6797 Remote Similarity NPD5736 Approved
0.6792 Remote Similarity NPD5404 Approved
0.6792 Remote Similarity NPD2935 Discontinued
0.6792 Remote Similarity NPD5406 Approved
0.6792 Remote Similarity NPD5408 Approved
0.6792 Remote Similarity NPD5405 Approved
0.6788 Remote Similarity NPD5403 Approved
0.6786 Remote Similarity NPD6801 Discontinued
0.678 Remote Similarity NPD7993 Clinical (unspecified phase)
0.6774 Remote Similarity NPD7699 Phase 2
0.6774 Remote Similarity NPD7700 Phase 2
0.6768 Remote Similarity NPD5401 Approved
0.6768 Remote Similarity NPD2533 Approved
0.6768 Remote Similarity NPD7422 Clinical (unspecified phase)
0.6768 Remote Similarity NPD2532 Approved
0.6768 Remote Similarity NPD2534 Approved
0.6759 Remote Similarity NPD690 Clinical (unspecified phase)
0.6752 Remote Similarity NPD230 Phase 1
0.675 Remote Similarity NPD2346 Discontinued
0.675 Remote Similarity NPD2343 Clinical (unspecified phase)
0.6746 Remote Similarity NPD2393 Clinical (unspecified phase)
0.6737 Remote Similarity NPD8319 Approved
0.6737 Remote Similarity NPD8320 Phase 1
0.6731 Remote Similarity NPD6233 Phase 2
0.6731 Remote Similarity NPD7715 Approved
0.6731 Remote Similarity NPD7714 Approved
0.6731 Remote Similarity NPD7713 Phase 3
0.6725 Remote Similarity NPD4381 Clinical (unspecified phase)
0.6724 Remote Similarity NPD7184 Clinical (unspecified phase)
0.6715 Remote Similarity NPD1238 Approved
0.671 Remote Similarity NPD7095 Approved
0.6707 Remote Similarity NPD6799 Approved
0.6705 Remote Similarity NPD3818 Discontinued
0.6703 Remote Similarity NPD6534 Approved
0.6703 Remote Similarity NPD6535 Approved
0.6691 Remote Similarity NPD1931 Clinical (unspecified phase)
0.6691 Remote Similarity NPD1930 Approved
0.6691 Remote Similarity NPD1929 Approved
0.6687 Remote Similarity NPD2438 Suspended
0.6686 Remote Similarity NPD1934 Approved
0.6686 Remote Similarity NPD5537 Clinical (unspecified phase)
0.6686 Remote Similarity NPD6168 Clinical (unspecified phase)
0.6686 Remote Similarity NPD6166 Phase 2
0.6686 Remote Similarity NPD7852 Clinical (unspecified phase)
0.6686 Remote Similarity NPD6167 Clinical (unspecified phase)
0.6685 Remote Similarity NPD6784 Approved
0.6685 Remote Similarity NPD6785 Approved
0.6684 Remote Similarity NPD7435 Discontinued
0.6667 Remote Similarity NPD7410 Clinical (unspecified phase)
0.6667 Remote Similarity NPD8389 Clinical (unspecified phase)
0.6667 Remote Similarity NPD7028 Phase 2
0.6667 Remote Similarity NPD7097 Phase 1
0.6667 Remote Similarity NPD6798 Discontinued
0.6667 Remote Similarity NPD7804 Clinical (unspecified phase)
0.6647 Remote Similarity NPD1465 Phase 2
0.6643 Remote Similarity NPD164 Approved
0.6629 Remote Similarity NPD7074 Phase 3
0.6628 Remote Similarity NPD3749 Approved
0.6627 Remote Similarity NPD7314 Clinical (unspecified phase)
0.6626 Remote Similarity NPD4109 Clinical (unspecified phase)
0.6626 Remote Similarity NPD4110 Phase 3
0.6625 Remote Similarity NPD7305 Phase 1
0.6625 Remote Similarity NPD2799 Discontinued
0.6624 Remote Similarity NPD8032 Phase 2
0.661 Remote Similarity NPD3751 Discontinued
0.6609 Remote Similarity NPD6959 Discontinued
0.6594 Remote Similarity NPD7798 Approved
0.6577 Remote Similarity NPD9545 Approved
0.6575 Remote Similarity NPD4869 Clinical (unspecified phase)
0.6573 Remote Similarity NPD7054 Approved
0.6573 Remote Similarity NPD4061 Clinical (unspecified phase)
0.6571 Remote Similarity NPD7229 Phase 3
0.657 Remote Similarity NPD3882 Suspended
0.6564 Remote Similarity NPD7874 Approved
0.6564 Remote Similarity NPD7875 Clinical (unspecified phase)
0.6561 Remote Similarity NPD6859 Clinical (unspecified phase)
0.6561 Remote Similarity NPD2313 Discontinued
0.6552 Remote Similarity NPD1609 Clinical (unspecified phase)
0.655 Remote Similarity NPD2801 Approved
0.6545 Remote Similarity NPD6823 Phase 2
0.6543 Remote Similarity NPD6005 Phase 3
0.6543 Remote Similarity NPD6004 Phase 3
0.6543 Remote Similarity NPD6002 Phase 3
0.6543 Remote Similarity NPD5763 Approved
0.6543 Remote Similarity NPD6003 Clinical (unspecified phase)
0.6543 Remote Similarity NPD6006 Clinical (unspecified phase)
0.6543 Remote Similarity NPD5762 Approved
0.6538 Remote Similarity NPD6832 Phase 2
0.6536 Remote Similarity NPD7472 Approved
0.6528 Remote Similarity NPD5955 Clinical (unspecified phase)
0.6528 Remote Similarity NPD2067 Discontinued
0.6526 Remote Similarity NPD6782 Approved
0.6526 Remote Similarity NPD6780 Approved
0.6526 Remote Similarity NPD6778 Approved
0.6526 Remote Similarity NPD6779 Approved
0.6526 Remote Similarity NPD6776 Approved
0.6526 Remote Similarity NPD6781 Approved
0.6526 Remote Similarity NPD6777 Approved
0.6525 Remote Similarity NPD5909 Discontinued
0.6522 Remote Similarity NPD4308 Phase 3
0.6519 Remote Similarity NPD4338 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data